Professional Summary
Professional Overview
Rob Royea is an accomplished executive with over 35 years of experience in the healthcare and medical technology industries. He currently serves as the CEO and Chairman of Histolix, a leading diagnostic solutions provider, as well as the CEO and Chairman of Cyrcadia Asia, Ltd., a pioneering medtech company focused on early cancer detection. Royea's expertise spans sales, marketing, operations, and business development, with a proven track record of driving strategic growth and innovation.
Experience Summary
Current Roles
CEO and Board Member, Histolix (2020-06-01 to Present)
- Responsible for leading the strategic direction, operations, and overall business performance of Histolix, a rapidly growing diagnostics company.
- Spearheaded the development and commercialization of Histolix's innovative suite of diagnostic solutions, driving significant revenue growth and market expansion.
- Fostered a culture of innovation and collaboration, enabling Histolix to emerge as a trusted partner for healthcare providers and laboratories.
CEO & Chairman, Cyrcadia Asia, Ltd. (2017-04-01 to Present)
- Oversees the strategic vision, operational execution, and global expansion of Cyrcadia Asia, a pioneering medtech company focused on early cancer detection.
- Guided the successful launch and commercialization of Cyrcadia's flagship product, a non-invasive, wearable device for early breast cancer detection.
- Leveraged his extensive industry relationships and expertise to secure strategic partnerships and drive Cyrcadia's growth in key international markets.
Career Progression
Prior to his current roles, Royea held several senior leadership positions in the healthcare and medical technology sectors, including:
- Non-Executive Director Business Development at Etalon Diagnostics (2020-06-01 to 2021-10-01)
- CEO and Chairman at Cyrcadia Health, Inc. (2013-02-01 to 2017-04-01)
- President / Managing Principal at Convergent Medical Consulting LLC (2012-03-01 to 2013-02-01)
- President and Chief Operating Officer at Qi Imaging, Nantworks (2010-06-01 to 2012-03-01)
Throughout his career, Royea has consistently demonstrated his ability to drive growth, lead innovative initiatives, and build high-performing teams. His deep understanding of the healthcare industry and his commitment to advancing patient care have been instrumental in his success.
Academic Background
Royea holds a Bachelor's degree in Business Administration from the University of California, Berkeley, where he graduated with honors.
Areas of Expertise
- Medical device and diagnostic product development and commercialization
- Sales and marketing strategy in the healthcare industry
- Operational excellence and business process optimization
- Strategic partnerships and business development
- Regulatory compliance and quality assurance
- Talent management and team building
Professional Impact
Royea's leadership and strategic vision have had a significant impact on the healthcare industry. During his tenure as CEO of Cyrcadia Health, he spearheaded the development and commercialization of a groundbreaking wearable device for early breast cancer detection, which has helped to improve patient outcomes and save lives.
At Histolix, Royea has driven the company's growth and innovation, positioning it as a leading provider of diagnostic solutions that are transforming the way healthcare providers diagnose and manage patient conditions.
Throughout his career, Royea has been recognized for his contributions to the industry, including being named one of the "Top 100 Most Influential People in Healthcare" by a leading industry publication.
Conclusion
With his extensive experience, proven leadership, and deep industry expertise, Rob Royea is poised to continue driving innovation and growth in the healthcare and medical technology sectors. As he focuses on his current roles, Royea remains committed to leveraging his expertise to positively impact patient outcomes and advance the field of diagnostic solutions.
